Nucleophosmin (NPM, B23) is an abundant nucleolar phosphoprotein involved in ribosome
biogenesis, and interacts with tumor suppressor proteins p53 and Rb. Here we show that …

We define the activity and mechanisms of action of a small molecule lead compound for
cancer targeting. We show that the compound, BMH-21, has wide and potent antitumorigenic …

Aflatoxin M 1 (AFM 1 ) is a highly toxic compound found in milk. Its occurrence poses a threat
to the health of consumers, especially young children, and leads to economic losses due to …

Background Relatlimab plus nivolumab (anti–lymphocyte-activation gene 3 plus anti–programmed
death 1 [anti–LAG-3+anti–PD-1]) has been approved by the FDA as a first-line …

Using a bio-oligo pull-down DNA-binding assay we investigated the binding capacity of
endogenous, DNA damage-induced p53 in human diploid fibroblasts to several p53-responsive …

The ability of six probiotic bacteria to bind a common food carcinogen, aflatoxin B 1 , was
assessed. The studied strains included Lactobacillus strains and one Bifidobacterium strain. …

Virus-based cancer vaccines are nowadays considered an interesting approach in the field
of cancer immunotherapy, despite the observation that the majority of the immune responses …

Manipulation of the activity of the p53 tumor suppressor pathway has demonstrated potential
benefit in preclinical mouse tumor models and has entered human clinical trials. We …

Complement-mediated killing of bacteria was monitored by flow cytometric, luminometric, and
conventional plate counting methods. A flow cytometric determination of bacterial viability …

DNA intercalation is a major therapeutic modality for cancer therapeutic drugs. The
therapeutic activity comes at a cost of normal tissue toxicity and genotoxicity. We have recently …